非PVC输液袋市场按产品类型、材料、销售和最终用户划分－全球预测（2026-2032年）

2025年非PVC空气输液袋市值为3.7194亿美元，预计2026年将成长至4.0707亿美元，年复合成长率为9.63%，到2032年将达到7.0819亿美元。

主要市场统计数据
基准年 2025	3.7194亿美元
预计年份：2026年	4.0707亿美元
预测年份：2032年	7.0819亿美元
复合年增长率 (%)	9.63%

简明实用的非PVC输液袋介绍：重点在于材料驱动因素、临床完整性和供应链影响

本执行摘要重点概述了非聚氯乙烯（PVC）输液袋，并阐述了其在现代输液治疗和医疗供应链中的作用。由于临床需求、监管关注和永续性考量，乙烯-醋酸乙烯酯共聚物（EVA）、聚乙烯（PE）和聚丙烯（PP）等非PVC材料正逐渐成为传统PVC解决方案的替代品。随着临床医生和采购负责人日益关注可萃取物和患者安全，向非PVC材料的转变正在重塑产品设计、製造流程和检验要求。

材料创新、监管压力、环境问题以及不断变化的医疗服务模式如何改变非PVC输液袋生态系统

临床实务、生产製造和采购的变化正在重塑非聚氯乙烯（PVC）输液袋的市场模式。首先，材料创新正在加速发展。製造商正在改进乙烯-醋酸乙烯酯共聚物（EVA）、聚乙烯和聚丙烯的配方，以平衡材料的柔软性、阻隔性能和与灭菌製程的兼容性。这些进步降低了与可萃取物相关的临床风险，同时实现了更多样化的输液袋规格和填充量，最终支持更广泛的治疗方法。

评估美国关税到2025年对输液产品筹资策略、供应链韧性和供应商关係的下游影响

美国关税的累积影响将持续到2025年，正在影响非PVC输液袋价值链中的筹资策略、成本结构和供应商关係。关税调整增加了许多医疗保健采购商进口零件和成品的实际到岸成本，迫使买家和製造商重新评估供应商选择和采购合约。为此，一些供应商加快了本地化进程，而另一些供应商则专注于提高营运效率和价值工程，以在不违反规定的前提下保持价格竞争力。

深入了解如何将产品类型、材料选择、终端用户需求和生产能力考量与临床和商业性优先事项相匹配。

细分市场分析揭示了製造商和采购商应重点关注的研发和采购领域，以满足临床和营运需求。按产品类型分類的细分市场突显了需求的频谱，从用于常规输液的单腔输液袋到多腔输液袋（包括三腔系统），后者可实现更复杂的预混合料疗法。尤其值得关注的是双腔输液袋，本文分析了带有排气口和没有排气口的两种设计，这些设计会影响适应症、给药技术以及与特定输液器和接头的兼容性。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和营运要务正在影响製造、采购和合规策略。

区域趋势将对非PVC输液袋的生产决策、监管策略和市场推广方式产生重大影响。在美洲，需求模式正朝着医院大批量需求和家庭输液解决方案需求成长并存的方向发展。区域製造商和经销商越来越重视快速补货、服务等级协议和合规文件，以满足买家的期望。供应链的韧性至关重要，这促使他们专注于近岸外包机会，并与成熟的区域加工商合作，以缩短前置作业时间并降低关税风险。

透过材料科学、製造柔软性以及上市后的监管和临床支持，使您的公司脱颖而出，满足多样化的客户需求。

主要企业层面洞察凸显了领先的製造商和供应商如何凭藉其材料专业知识、柔软性的契约製造和法规支援服务脱颖而出。成功的公司往往会投资于聚合物科学能力和内部测试，以加速乙烯-醋酸乙烯酯共聚物、聚乙烯和聚丙烯解决方案的合格，从而缩短证明其与灭菌工艺兼容性以及记录可萃取物和可萃取物特性所需的时间。

为製造商和买家提供策略和营运建议，以增强材料检验、供应链韧性和以客户为中心的产品系列

针对行业领导者的具体建议着重于使产品开发、供应链策略和商业性合作与不断变化的临床和采购重点保持一致。首先，应优先进行材料合格项目，检验乙烯-醋酸乙烯酯共聚物、聚乙烯和聚丙烯配方，从而获得清晰的临床证据和监管文件。投资于标准化测试通讯协定和透明的文件记录将缩短医院和门诊医疗机构的合格时间。

透过严谨的多方法研究途径，结合相关人员访谈、技术文献综述和供应链分析，检验了具有实务意义的产业洞察。

本分析的调查方法结合了与关键相关人员的直接对话、对二手文献的综合分析以及跨部门检验，以确保提供可靠的实用见解。主要研究内容包括与医院、门诊中心和居家照护机构的采购经理、临床技术人员和护理人员进行结构化访谈和咨询，特别关注养老院和私人住宅中的易用性需求。这些访谈最终评估了单腔、双腔和三腔配置的设备的易用性、容量偏好和临床适用性。

前瞻性综合分析重点在于材料权衡、区域采购要求和服务主导的差异化，以推动未来发展。

总之，非聚氯乙烯（PVC）输液袋处于材料创新、不断发展的医疗服务模式和日益严格的供应链监管的交汇点。乙烯-醋酸乙烯酯共聚物（EVA）、聚乙烯和聚丙烯各自具有独特的性能权衡，这些权衡会影响灭菌策略、可萃取物风险管理和生产过程。产品类型的差异化——从单腔装置到多腔系统，再到有或没有排气口的双腔设计——能够实现客製化的临床解决方案，但也需要谨慎选择供应商并进行相容性测试。

目录

第一章：序言

第二章调查方法

• 研究设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查前提
• 调查限制

第三章执行摘要

• 首席体验长观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会地图
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 非PVC输液袋市场（依产品类型划分）

• 单人房
• 三室型
• 双腔型
  • 附通风口
  • 无通风口

9. 非PVC输液袋市场（依材料分类）

• 乙烯-醋酸乙烯酯
• 聚乙烯
• 聚丙烯

10. 非PVC输液袋市场（以销量计）

• 250～500ml
• 500毫升或以上
• 250毫升或以下
  • 100～250ml
  • 100毫升或以下

第十一章 非PVC输液袋市场（依最终用户划分）

• 门诊治疗中心
• 居家医疗
  • 辅助生活设施
  • 私人住宅
• 医院

12. 各地区非PVC输液袋市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章 非PVC输液袋市场（依类别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

14. 各国非PVC输液袋市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十六章美国非PVC输液袋市场

第十七章：中国非PVC输液袋市场

第十七章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Angiplast Pvt. Ltd.
• B. Braun Melsungen AG
• Baxter International Inc.
• Fresenius Kabi AG
• Haemotronic SpA
• ICU Medical, Inc.
• JW Life Science Corp.
• Kraton Corporation
• Medline Industries, Inc.
• Otsuka Pharmaceutical Factory, Inc.
• PolyCine GmbH
• RENOLIT SE
• Shanghai Solve Care Co., Ltd.
• Sippex IV Bag Manufacturing Co., Ltd.
• Technoflex SAS

The Non-PVC Empty IV Bags Market was valued at USD 371.94 million in 2025 and is projected to grow to USD 407.07 million in 2026, with a CAGR of 9.63%, reaching USD 708.19 million by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 371.94 million
Estimated Year [2026]	USD 407.07 million
Forecast Year [2032]	USD 708.19 million
CAGR (%)	9.63%

A concise and action-oriented introduction to non-PVC empty IV bags highlighting material drivers, clinical alignment, and supply chain implications

This executive summary presents a focused introduction to non-PVC empty IV bags, framing their role in contemporary infusion therapy and healthcare supply chains. Non-PVC materials such as ethylene vinyl acetate, polyethylene, and polypropylene have emerged as alternatives to traditional PVC solutions, driven by clinical concerns, regulatory attention, and sustainability considerations. As clinicians and procurement professionals increasingly scrutinize materials for leachables, extractables, and patient safety, the shift toward non-PVC formats is reshaping product design, manufacturing processes, and validation requirements.

The landscape is also influenced by device configuration choices that align with therapy complexity and user needs. Product types range from single chamber bags for standard infusions to multi-chamber systems that enable separation of components until point of use; within these options, two chamber formats may be offered with or without vent ports to meet application-specific requirements. Capacity choices affect logistics and care delivery models, including smaller formats that support home infusion and larger volumes tailored to inpatient workflows. End users encompass ambulatory care centers, hospitals, and home care settings, with the latter including assisted living facilities and private residences.

Taken together, these dynamics underline the importance of integrating clinical performance, material science, and supply chain resilience when evaluating non-PVC empty IV bag options. This introduction establishes the foundational considerations that inform the deeper analysis in the subsequent sections of the report.

How material innovation, regulatory pressures, environmental concerns, and shifting care delivery models are transforming the non-PVC empty IV bag ecosystem

Transformative shifts are reshaping the non-PVC empty IV bag landscape across clinical practice, manufacturing, and procurement. First, material innovation has accelerated: manufacturers are refining ethylene vinyl acetate, polyethylene, and polypropylene formulations to balance flexibility, barrier properties, and compatibility with sterilization processes. These advances reduce clinical risk related to leachables while enabling a wider range of bag geometries and fill volumes, which in turn supports more diverse therapy regimens.

Second, regulatory and environmental pressures are prompting reassessment of single-use device lifecycles and disposal strategies. Healthcare systems are increasingly evaluating the downstream environmental footprint of infusion products alongside traditional safety metrics, pushing suppliers to document life-cycle impacts and to pursue recyclable or lower-impact materials without compromising sterility and performance. Meanwhile, supply chain strategies are undergoing a tactical pivot: organizations are prioritizing supplier diversification, regional manufacturing capacity, and transparent raw material sourcing to mitigate disruption risks.

Third, care delivery models are evolving. The growth of home care and ambulatory services is shifting demand toward smaller capacity formats and user-friendly designs that support non-clinical caregivers in assisted living facilities and private residences. At the same time, hospitals continue to require a range of capacities, from up to 100 mL formats to above 500 mL systems, and configurations that support compounding or multi-component therapies. These converging trends are driving product differentiation, requiring manufacturers to align development roadmaps with clinical workflows and procurement priorities.

Assessing the downstream effects of U.S. tariff measures through 2025 on procurement strategies, supply chain resilience, and supplier relationships in infusion products

The cumulative impact of United States tariff actions implemented through 2025 has influenced sourcing strategies, cost structures, and supplier relationships within the non-PVC empty IV bag value chain. Tariff changes have increased the effective landed cost of imported components and finished goods for many healthcare purchasers, prompting buyers and manufacturers to revisit supplier footprints and procurement contracts. In response, some suppliers accelerated regionalization efforts, while others focused on improving operational efficiencies and value engineering to maintain competitive pricing without compromising compliance.

Additionally, the tariff environment heightened the emphasis on transparency in the upstream supply chain. Procurement teams intensified efforts to map raw material origins for ethylene vinyl acetate, polyethylene, and polypropylene resins, seeking to understand exposure to trade measures and to negotiate supply agreements that include contingency clauses. Manufacturers facing elevated import costs also revisited inventory strategies and payment terms, balancing capital tied up in safety stocks against the risk of short-notice supply interruptions.

Clinically, the tariff-driven shifts reinforced the imperative for robust supplier qualification processes. Hospitals, ambulatory centers, and home care providers demanded clearer traceability, quality documentation, and localized support capabilities. Collectively, these adjustments illustrate how trade policy variables can catalyze longer-term structural changes in sourcing approaches, vertical integration considerations, and collaborative risk-sharing between buyers and manufacturers.

Deep segmentation-driven insights that align product type, material selection, end-user needs, and capacity considerations to clinical and commercial priorities

Segmentation insights reveal where manufacturers and buyers should concentrate development and procurement efforts to align with clinical and operational needs. Product type segmentation highlights the demand spectrum from single chamber bags intended for routine infusions to multi-chamber formats, including three chamber systems that enable more complex, pre-mixed therapies. Two chamber configurations deserve particular attention because they are studied across designs with and without vent ports; the presence or absence of a vent port influences application suitability, administration technique, and compatibility with specific IV sets and connectors.

Material segmentation frames performance expectations and manufacturing considerations. Ethylene vinyl acetate offers a balance of flexibility and chemical compatibility, polyethylene brings favorable cost and processability characteristics, and polypropylene is chosen for its higher temperature tolerance and strength. Each polymer family imposes unique requirements on sterilization validation, extractables and leachables testing, and packaging design, so material selection must align with intended clinical use and sterilization pathways.

End user segmentation underscores differing procurement and product requirements across settings. Ambulatory care centers typically prioritize ease of handling and throughput, hospitals require a broad capacity range and compatibility with compounding workflows, and home care prioritizes portability and caregiver usability, with subsegments including assisted living facilities and private residences. Capacity segmentation further clarifies logistics and usage patterns: categories ranging from up to 100 mL and 100-250 mL within the up to 250 mL band, to 250-500 mL and above 500 mL formats, shape inventory planning, device handling protocols, and infusion regimen suitability. Integrating these segmentation lenses supports targeted product development and differentiated market strategies.

Regional dynamics and operational imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape manufacturing, procurement, and compliance strategies

Regional dynamics materially influence manufacturing decisions, regulatory strategies, and go-to-market approaches for non-PVC empty IV bags. In the Americas, demand patterns favor a mix of high-volume hospital requirements and a growing appetite for home infusion solutions; regional manufacturers and distributors increasingly emphasize rapid replenishment, service-level agreements, and compliance documentation to meet purchaser expectations. Supply chain resilience is a priority, prompting interest in nearshoring opportunities and partnerships with established regional converters to reduce lead times and mitigate tariff exposure.

Across Europe, the Middle East & Africa, regulatory harmonization, environmental reporting requirements, and waste management policies are significant drivers of product design and facility investment. Suppliers that can demonstrate validated pathways for recyclable or lower-impact materials, alongside robust quality systems and clinical evidence supporting safety, gain strategic advantage in procurement dialogs. Local manufacturing capacity and logistical networks also determine how quickly new non-PVC formulations can be scaled into hospital and ambulatory channels.

In the Asia-Pacific region, manufacturers are both major producers of polymer resins and important converters of medical-grade films and films-to-bag products. This concentration of upstream capability supports competitive cost structures but also introduces sensitivity to global trade dynamics. Buyers and suppliers operating in Asia-Pacific prioritize supplier audits, adherence to international quality standards, and manufacturing flexibility to respond to diverse regional clinical practices and capacity requirements. Taken together, regional considerations require tailored commercial approaches and risk management practices that reflect local regulations, distribution systems, and clinical use patterns.

Corporate differentiation through material science, manufacturing flexibility, and post-market regulatory and clinical support to meet diverse buyer needs

Key company-level insights center on how leading manufacturers and suppliers differentiate through material expertise, contract manufacturing flexibility, and regulatory support services. Successful companies tend to invest in polymer science capabilities and in-house testing to accelerate qualification of ethylene vinyl acetate, polyethylene, and polypropylene solutions, thereby shortening the time required to demonstrate compatibility with sterilization processes and to document extractables and leachables profiles.

Operationally, firms that have diversified their converter networks and established regional manufacturing nodes show greater agility in responding to tariff-induced cost shifts and localized demand surges. These companies often offer modular production lines that can handle single chamber, two chamber, and three chamber formats, including variations for two chamber systems with and without vent ports. Such flexibility enables rapid changeovers to support customer-specific pack-outs and labeling requirements.

Commercially, leaders provide robust post-market support, including clinical liaison services, quality documentation packages, and training resources tailored to hospitals, ambulatory care centers, and home care providers. They also design capacity assortments spanning up to 100 mL formats to above 500 mL options to address the diverse needs of end users. In addition, partnerships with raw material suppliers and investments in traceability systems strengthen sourcing resilience and enhance customer confidence during supplier qualification processes.

Strategic and operational recommendations for manufacturers and buyers to strengthen material validation, supply resilience, and customer-focused product portfolios

Actionable recommendations for industry leaders focus on aligning product development, supply chain strategy, and commercial engagement to evolving clinical and procurement priorities. First, prioritize material qualification programs that validate ethylene vinyl acetate, polyethylene, and polypropylene formulations across sterilization cycles and extractables testing, enabling clear clinical evidence and regulatory dossiers. Investing in standardized testing protocols and transparent documentation will shorten qualification timelines for hospitals and ambulatory providers.

Second, build supply chain resilience by expanding regional manufacturing capacity and diversifying converters to reduce exposure to tariff volatility. Establishing contingency agreements with upstream resin suppliers and developing flexible inventory policies will reduce the risk of disruptive shortages while preserving working capital. Third, tailor product portfolios to end-user segmentation: design ergonomic, smaller capacity formats and simplified administration for home care and assisted living settings while maintaining higher-capacity, compounding-friendly formats for hospital environments. Include options for two chamber designs both with and without vent ports to address administration preferences.

Fourth, enhance commercial value by offering comprehensive supplier qualification packages, clinical education resources, and localized service capabilities. Fifth, incorporate environmental performance metrics into product development and communication strategies, documenting life-cycle impacts and disposal pathways to meet buyer sustainability expectations. Collectively, these steps will fortify market position and align offerings with the operational realities of modern healthcare delivery.

A rigorous multi-method research approach combining stakeholder interviews, technical literature review, and supply chain mapping to validate practical industry insights

The research methodology underpinning this analysis combines primary stakeholder engagement, secondary literature synthesis, and cross-functional validation to ensure robust and actionable insights. Primary inputs included structured interviews and consultations with procurement leaders, clinical engineers, and nursing staff across hospitals, ambulatory centers, and home care providers, with particular attention to usability requirements for assisted living facilities and private residences. These engagements informed assessments of device handling, volume preferences, and clinical compatibility for single chamber, two chamber, and three chamber formats.

Secondary investigation focused on technical literature, regulatory guidance, and materials science publications that address polymer behavior, sterilization compatibility, and extractables and leachables considerations for ethylene vinyl acetate, polyethylene, and polypropylene. Manufacturer technical bulletins and quality documentation were reviewed to understand manufacturing processes, sterilization methods, and packaging considerations. Cross-validation exercises compared primary stakeholder feedback with secondary findings to identify convergent themes and to surface operational trade-offs.

Finally, the analysis incorporated supply chain mapping and risk assessment techniques to evaluate regional manufacturing capacity, tariff exposure, and logistical constraints. Quality control of the study was maintained through iterative reviews with subject-matter experts in polymer chemistry, clinical infusion practice, and regulatory affairs to ensure that conclusions are grounded in practical, evidence-based considerations.

A forward-looking synthesis emphasizing material trade-offs, regional sourcing imperatives, and service-led differentiation for future readiness

In conclusion, non-PVC empty IV bags are at the intersection of materials innovation, evolving care delivery models, and heightened supply chain scrutiny. Ethylene vinyl acetate, polyethylene, and polypropylene each present distinct performance trade-offs that influence sterilization strategies, extractables risk management, and manufacturing processes. Product type differentiation-from single chamber units to multi-chamber systems and two chamber designs with or without vent ports-enables tailored clinical solutions but also requires meticulous supplier qualification and compatibility testing.

Regional dynamics and tariff developments through 2025 have accelerated the need for procurement agility and localized manufacturing options, while environmental and regulatory expectations are increasing the importance of lifecycle transparency and waste management plans. End users across ambulatory care centers, hospitals, assisted living facilities, and private residences demand different form factors and service levels, so companies that align material science capabilities with flexible manufacturing and strong post-market support will be best positioned to meet those needs.

Overall, the path forward requires coordinated investment in material validation, supply chain diversification, and customer-centered commercial practices to deliver safe, compliant, and operationally effective non-PVC infusion solutions.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-PVC Empty IV Bags Market, by Product Type

• 8.1. Single Chamber
• 8.2. Three Chamber
• 8.3. Two Chamber
  • 8.3.1. With Vent Port
  • 8.3.2. Without Vent Port

9. Non-PVC Empty IV Bags Market, by Material

• 9.1. Ethylene Vinyl Acetate
• 9.2. Polyethylene
• 9.3. Polypropylene

10. Non-PVC Empty IV Bags Market, by Capacity

• 10.1. 250-500 ML
• 10.2. Above 500 ML
• 10.3. Up to 250 ML
  • 10.3.1. 100-250 ML
  • 10.3.2. Up to 100 ML

11. Non-PVC Empty IV Bags Market, by End User

• 11.1. Ambulatory Care Centers
• 11.2. Home Care
  • 11.2.1. Assisted Living Facilities
  • 11.2.2. Private Residences
• 11.3. Hospital

12. Non-PVC Empty IV Bags Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Non-PVC Empty IV Bags Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Non-PVC Empty IV Bags Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Non-PVC Empty IV Bags Market

16. China Non-PVC Empty IV Bags Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. Angiplast Pvt. Ltd.
• 17.6. B. Braun Melsungen AG
• 17.7. Baxter International Inc.
• 17.8. Fresenius Kabi AG
• 17.9. Haemotronic SpA
• 17.10. ICU Medical, Inc.
• 17.11. JW Life Science Corp.
• 17.12. Kraton Corporation
• 17.13. Medline Industries, Inc.
• 17.14. Otsuka Pharmaceutical Factory, Inc.
• 17.15. PolyCine GmbH
• 17.16. RENOLIT SE
• 17.17. Shanghai Solve Care Co., Ltd.
• 17.18. Sippex IV Bag Manufacturing Co., Ltd.
• 17.19. Technoflex SAS

LIST OF FIGURES

• FIGURE 1. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL NON-PVC EMPTY IV BAGS MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL NON-PVC EMPTY IV BAGS MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 12. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY THREE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY THREE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY THREE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY WITH VENT PORT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY WITH VENT PORT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY WITH VENT PORT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY WITHOUT VENT PORT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY WITHOUT VENT PORT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY WITHOUT VENT PORT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY 250-500 ML, BY REGION, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY 250-500 ML, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY 250-500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ABOVE 500 ML, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ABOVE 500 ML, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ABOVE 500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, BY REGION, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY 100-250 ML, BY REGION, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY 100-250 ML, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY 100-250 ML, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 100 ML, BY REGION, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 100 ML, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 100 ML, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRIVATE RESIDENCES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRIVATE RESIDENCES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRIVATE RESIDENCES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 64. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 65. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 66. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 67. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 68. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 69. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 70. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 71. AMERICAS NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 72. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 73. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 74. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 75. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 76. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 77. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 78. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 79. NORTH AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 80. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 81. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 82. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 83. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 84. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 85. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 86. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 87. LATIN AMERICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 89. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 90. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 91. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 92. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 93. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 94. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 95. EUROPE, MIDDLE EAST & AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 96. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 97. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 98. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 99. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 100. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 101. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 102. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 103. EUROPE NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 104. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 105. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 106. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 107. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 108. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 109. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 110. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 111. MIDDLE EAST NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 112. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 113. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 114. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 115. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 116. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 117. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 118. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 119. AFRICA NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 120. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 121. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 122. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 123. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 124. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 125. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 126. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 127. ASIA-PACIFIC NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 128. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 129. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 130. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 131. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 132. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 133. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 134. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 135. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 136. ASEAN NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 137. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 138. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 139. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 140. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 141. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 142. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 143. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 144. GCC NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 145. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 146. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 147. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 148. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 149. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 150. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 151. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 152. EUROPEAN UNION NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 153. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 154. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 155. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 156. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 157. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 158. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 159. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 160. BRICS NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 161. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 162. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 163. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 164. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 165. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 166. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 167. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 168. G7 NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 169. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 170. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 171. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 172. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 173. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 174. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 175. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 176. NATO NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 177. GLOBAL NON-PVC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 178. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 179. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 180. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 181. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 182. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 183. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 184. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 185. UNITED STATES NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
• TABLE 186. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 187. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
• TABLE 188. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY TWO CHAMBER, 2018-2032 (USD MILLION)
• TABLE 189. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 190. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
• TABLE 191. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY UP TO 250 ML, 2018-2032 (USD MILLION)
• TABLE 192. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 193. CHINA NON-PVC EMPTY IV BAGS MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)